Evolent Health had announced the completion of a USD100 million Series B funding round. The world's leading provider of transformation solutions to health systems would utilize the funds to expand its population health and risk management platform. It also aims to broaden its national health network in health systems as well as value based care experts.
The total funding of the firm has already reached USD124.5 million and leading the participation are the Advisory Board Company, the UPMC Health Plan and TPG Growth.
According to Evolent CEO Frank Williams, "In an environment of rising costs and wide variations in care quality, creating clinical value is challenging but critically important- and readily achievable with the right partner. With our physician and provider partners, Evolent is able to fully align with the clinical and financial imperatives of the health care system, With this investment, we can extend our reach to serve even more systems in more markets."
The company's expansion plans include the further use of market-proven tachnology, operational platform and expert member team. It works with leading health systems such as Piedmont Healthcare, WellStar Health System, Indiana University Health, MedStar Health and Premiere Health,
Join the Conversation